The ESMO-ECPC Cancer Survivorship Guide and Cancer Survivorship Plan is a unique care and cancer advocacy tool.
Cancer patient advocates can include it in their work.
Patient empowerment at EU level - Katja Neubauer, Deputy Head of Unit, Healthcare Systems Unit, DG Sanco for the 8th European Patients' Rights Day in Brussels, May 12th 2014
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
Is HTA purely technical?
drivers for patient involvement in HTA
patient participation or tokenism
medicines do not reach patients due to delays in HTA evaluation
need for harmonized HTA
Nurse Practitioner (NP) is an advanced practice nurse who works collaboratively with doctors to diagnose and treat various illnesses. NPs routinely take medical history, perform physical exams, discuss diagnostic results and educate patients. Learn more at Bay Regional Cancer Center.
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
The value off engaging patients in researchSimon Denegri
This is a talk I gave at the Council of Academic Hospitals of Ontario (CAHO) 'Healthier Wealthier, Smarter' conference in Toronto on 1st June 2015. Do visit their new website: http://caho-hospitals.com/
Patient empowerment at EU level - Katja Neubauer, Deputy Head of Unit, Healthcare Systems Unit, DG Sanco for the 8th European Patients' Rights Day in Brussels, May 12th 2014
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
Is HTA purely technical?
drivers for patient involvement in HTA
patient participation or tokenism
medicines do not reach patients due to delays in HTA evaluation
need for harmonized HTA
Nurse Practitioner (NP) is an advanced practice nurse who works collaboratively with doctors to diagnose and treat various illnesses. NPs routinely take medical history, perform physical exams, discuss diagnostic results and educate patients. Learn more at Bay Regional Cancer Center.
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
The value off engaging patients in researchSimon Denegri
This is a talk I gave at the Council of Academic Hospitals of Ontario (CAHO) 'Healthier Wealthier, Smarter' conference in Toronto on 1st June 2015. Do visit their new website: http://caho-hospitals.com/
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...jangeissler
A snapshot of EUPATI: Why the educated patient is so vital to success in clinical trials - Jan Geissler - EUPATI Director - presented at DIA EuroMeeting on 6 March 2013 in Amsterdam
This presentation is prepared for Asia Pacific Union Conference about patient's right on tuberculosis, in Hilton Hotel, Sydney, Australia, on September 1, 2015.
Tricia Strusowski, MS, RN
Director, Cancer Care Management
Helen F. Graham Cancer Center
Christiana Care Health System
Sharon Gentry, RN, MSN, AOCN, CBCN
Breast Health Navigator
Derrick L. Davis Forsyth Regional Cancer Center
Robert A.S. Suntay
Robert Abad Santos Suntay is the co-founder and managing director of Carewell – the Cancer Resource and Wellness Community Foundation, Inc. Carewell is a volunteer-driven, non-stock, non-profit organization that provides support, education, and most important: hope – to persons with cancer and their loved ones.
Carewell provides psycho-social support resources and programs that enable all persons affected by cancer to cope more successfully with the myriad demands of the illness. Carewell offers support groups and counseling, medical consults and referrals, wellness and fun activities, talks and seminars, and access to information and support from around the world thanks to The Cancer Support Community – a global network of cancer support organizations of which Carewell is a member.
Prior to his involvement at Carewell, Bobbit Suntay was a longtime educator. He was formerly the high school principal of Xavier School, and an assistant professor of education and managing director of the Ateneo de Manila University Center for Educational Development. He is currently a board member of The Beacon School, The Beacon Academy, and The Principals’ Center at Harvard University.
Workshop 6 - Brainstorming & Policy Development session: Training, information and education of MDs
"Training package on RD for medical students"
Bernd Quadder, Deutsche Sarcoidose Vereinigung,
Germany
A protocol for the management of breast cancer developed by the multidisciplinary oncology team at University of Nigeria Teaching Hospital, fully adapted to our environment
As part of the 2018 Make Sense
campaign, ECPC organised an event at the European Parliament under the
theme Survivorship: Life with, through and beyond head and neck cancer.
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...jangeissler
A snapshot of EUPATI: Why the educated patient is so vital to success in clinical trials - Jan Geissler - EUPATI Director - presented at DIA EuroMeeting on 6 March 2013 in Amsterdam
This presentation is prepared for Asia Pacific Union Conference about patient's right on tuberculosis, in Hilton Hotel, Sydney, Australia, on September 1, 2015.
Tricia Strusowski, MS, RN
Director, Cancer Care Management
Helen F. Graham Cancer Center
Christiana Care Health System
Sharon Gentry, RN, MSN, AOCN, CBCN
Breast Health Navigator
Derrick L. Davis Forsyth Regional Cancer Center
Robert A.S. Suntay
Robert Abad Santos Suntay is the co-founder and managing director of Carewell – the Cancer Resource and Wellness Community Foundation, Inc. Carewell is a volunteer-driven, non-stock, non-profit organization that provides support, education, and most important: hope – to persons with cancer and their loved ones.
Carewell provides psycho-social support resources and programs that enable all persons affected by cancer to cope more successfully with the myriad demands of the illness. Carewell offers support groups and counseling, medical consults and referrals, wellness and fun activities, talks and seminars, and access to information and support from around the world thanks to The Cancer Support Community – a global network of cancer support organizations of which Carewell is a member.
Prior to his involvement at Carewell, Bobbit Suntay was a longtime educator. He was formerly the high school principal of Xavier School, and an assistant professor of education and managing director of the Ateneo de Manila University Center for Educational Development. He is currently a board member of The Beacon School, The Beacon Academy, and The Principals’ Center at Harvard University.
Workshop 6 - Brainstorming & Policy Development session: Training, information and education of MDs
"Training package on RD for medical students"
Bernd Quadder, Deutsche Sarcoidose Vereinigung,
Germany
A protocol for the management of breast cancer developed by the multidisciplinary oncology team at University of Nigeria Teaching Hospital, fully adapted to our environment
As part of the 2018 Make Sense
campaign, ECPC organised an event at the European Parliament under the
theme Survivorship: Life with, through and beyond head and neck cancer.
‘Freedom from pain should be seen as a right of every cancer patient and access to pain therapy as a measure of respect for the right in Lesotho
There are several barriers to effective pain control in both A focus on essential pain medicationaccessibility and Pain management cancer and / or HIV/AIDS. Such barriers could be patient related; clinician-related; societal/health system; and political and/or legal-related.
Slides to accompany presentation by Prof Jourik Gietema, University of Groningen, Netherlands @UnivGroningen, as part of the "Examples of patient-oriented apps" panel.
Survivor Care: an app to enhance survivors’ quality of life
mHealth can help in innovating cancer care pathways: Prof Giatema’s app is a perfect example of how to mix scientific validated medical recommendations with the latest mHealth technology to provide cancer patients with state of the art and cost-effective survivorship care.
----
This was presented at the "Unleashing the mHealth potential for cancer patients" event held on Wednesday 25th May 2016 (16:30-18:30pm) in the European Parliament.
#mHealthCancer
"mHealth and eHealth are becoming realities in Europe: this is demonstrated by the growing size of mHealth apps’ market, by the raising investments in eHealth infrastructures and by the fast adoption, at various degrees, of mHealth applications by patients.
The burden of cancer is also raising: more than 10 million EU citizens are affected by cancer, incidence and prevalence are growing, and the socio-economic impact of cancer heavily burdens both healthcare systems and cancer patients.
The recent political agreement on the text the General Data Protection Regulation and the production of the Privacy Code of Conduct mHealth apps further stir the debate regarding the use of new mHealth technologies within cancer care pathways.
Are cancer patients enjoying the benefits of mHealth?
In which field can cancer patients profit the most from mHealth apps?
Is the regulatory framework supporting the development of useful and safe mHealth apps for cancer patients?
Are there other structural obstacles to the full integration of mHealth apps in the cancer patients’ journey?"
The event will be hosted by MEP Cristian-Silviu Busoi (EPP, Romania), one of ECPC closest champions within the European Parliament and a knowledgeable supporter of the development of eHealth/mHealth in Europe.
The event was followed by a cocktail reception.
Join the discussion on Twitter using #mHealthCancer The event is part of the initiatives for the
2016 European Week Against Cancer #EWAC2016
More information can be found on the European Cancer Patient Coalition's website:
http://www.ecpc.org/pressroom/events/icalrepeat.detail/2016/04/26/61/-/-
FINAL-Advocacy-Module 6 Research for advocatesCforCourage
Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body.
Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and multiply (through a process called cell division) to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.
Sometimes this orderly process breaks down, and abnormal or damaged cells grow and multiply when they shouldn’t. These cells may form tumors, which are lumps of tissue. Tumors can be cancerous or not cancerous (benign).
Cancerous tumors spread into, or invade, nearby tissues and can travel to distant places in the body to form new tumors (a process called metastasis). Cancerous tumors may also be called malignant tumors. Many cancers form solid tumors, but cancers of the blood, such as leukemias, generally do not.
Benign tumors do not spread into, or invade, nearby tissues. When removed, benign tumors usually don’t grow back, whereas cancerous tumors sometimes do. Benign tumors can sometimes be quite large, however. Some can cause serious symptoms or be life threatening, such as benign tumors in the brain.
Differences between Cancer Cells and Normal Cells
How Does Cancer Develop?
Types of Genes that Cause Cancer
When Cancer Spreads
Tissue Changes that Are Not Cancer
Types of Cancer
Related Resources
Updated: October 11, 2021
If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “What Is Cancer? was originally published by the National Cancer Institute.”
From disease-centered to patient-centered communication in breast cancerKathi Apostolidis
Breast cancer patient perspectives and experiences in patient-doctor communication
Are physicians educated and skilled to communicate difficult diagnoses to cancer patients?
What is patient centered communication?
How doctors think
A experiência do Reino Unido sobre as Práticas Avançadas em Enfermagem foi tema da última reunião virtual, que aconteceu nesta quarta (24/11), do ciclo de intercâmbio promovido pela Organização Pan-Americana da Saúde no Brasil, pelo Conselho Federal de Enfermagem (Cofen) e pelo Centro Colaborador da OPAS/OMS para o Desenvolvimento da Pesquisa em Enfermagem da Universidade de São Paulo/Ribeirão. As palestrantes foram a diretora e a presidente do International Council of Nurses (ICN) do Reino Unido, Melaine Roger e Daniela Lehwaldt, respectivamente. Elas abordaram os avanços globais nas práticas em enfermagem, trouxeram casos do que acontece no Reino Unido e o porquê da importância dos enfermeiros e enfermeiras em práticas avançadas para os sistemas universais de saúde.
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
The psychological impact of living with and beyond cancer - reportAlex King
Earlier diagnosis and advances in treatment mean that more people are living with and beyond cancer,1 with approximately half of those diagnosed today living for ten years or more.2 Alongside positive clinical outcomes is the need to identify the key psychological challenges faced by individuals experiencing longterm cancer survival, and whether current provision of psychological support and services meet the needs of this relatively new group of patients. It is important to note that the psychological challenges faced during long-term survivorship are often not independent of those experienced at other points in a patient’s journey, including diagnosis, during or at completion of treatment, remission or at no evidence of disease (NED). As such, a broader view is necessary to ensure that psychological challenges faced in long-term survivorship are not addressed in isolation and individual impact is acknowledged.
Many European countries include referral pathways to psychological support in cancer care guidelines however, this is not always the case in the UK. For example, lung cancer guidelines do not include psychological assessment, referral pathways to psychological support or mention psychological burden.3 Existing guidance relating to the supportive and palliative care for adults with cancer was published by the National Institute for Health and Care Excellence (NICE) in 2004.4 Since then, the cancer treatment landscape has seen significant advances with earlier diagnosis and improved survival rates alongside changes within the wider environment including the advent of social media and other digital resources.
The ‘Psychological Support for Patients Living with Cancer - Patient Workshop’ aimed to identify the uniting, unmet psychological needs of people living with and beyond cancer. The workshop found the following key themes: • Prioritising quality of life (QoL) • Challenge of re-introduction to the community following treatment • The impact of cancer on families and carers
When addressing the provision of psychological support and ways in which current services could be improved, the following areas were discussed: • Integrating psychological support into the treatment pathway • Improving timing and communication • Securing timely support • Acknowledging differences • Getting support for families and carers
The wider environment, existing initiatives and the resulting workshop learnings will help inform MSD’s wider understanding of this topic and help to shape future planning regarding MSD’s contribution to support the psychological well-being of patients living with and beyond cancer.
Don’t miss our upcoming webinars. Subscribe today!
About this webinar:The importance of Cancer Rehabilitation The diagnosis and treatment of cancer can result in chronic side effects which interfere with a person’s ability to work, engage socially, and do daily activities. Awareness and understanding of cancer rehabilitation have increased greatly over the past decade. However, access to rehabilitation services remains limited across Canada. There is an urgent call to action to invest in systems and services that can promote the recovery and well-being of cancer survivors. This includes the early identification of physical side effects and the development of effective cancer rehabilitation treatments that can be supported and maintained by our health care system.About This Presenter:Jennifer M. Jones, PhDDr. Jennifer Jones is the Butterfield Drew Chair in Cancer Survivorship Research and the Director of the Cancer Rehabilitation and Survivorship Program at the Princess Margaret Cancer Centre. In addition, she is a Senior Scientist at the Princess Margaret Research Institute and an Associate Professor in the Department of Psychiatry (primary) and the Dalla Lana School of Public Health (cross-appointment) at University of Toronto.Dr. Jones’ most recent scholarly and professional activities have clustered around Translational research to inform clinical survivorship care. This clinical research platform specifically focuses on examining new approaches to predict, prevent and manage long-term adverse effects of cancer and its treatment and evaluating innovative models of follow-up care and support for the growing number of cancer survivors.
View the Video: https://bit.ly/importanceofcancerrehabyoutube
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
In this webinar, Dr. Popp will discuss everything you need to know about palliative care! This is an important webinar for colorectal cancer patients and their loved ones.
Similar to ESMO-ECPC Cancer Survivorship Guide (20)
Why Humanities & Art are important in medical educationKathi Apostolidis
Medicine graduates have to deal with complex human feelings and situations besides complex medical problems. Philosophy, humanities and art will help students to link medicine to its human dimension
Μπορεί η Ελλάδα να συνεχίσει να μην έχει εθνική πολιτική και τα απαραίτητα γι αυτό εργαλεία; Είναι άμεση ανάγκη να αποκτήσει η Ελλάδα το συντομότερο Εθνικό Σχέδιο Δράσης για τον έλεγχο του Καρκίνου και πληθυσμιακό Εθνικό Μητρώο Νεοπλασιών. Η Ευρωπαϊκή Κοινή Δράση για τον Ελεγχο του Καρκίνου (CANCON) αποτέλεσμα της συνεργασίας 17 χωρών μελών, 26 Ευρωπαϊκών επιστημονικών φορέων και οργανώσεων, 66 λοιπών εταίρων μεταξύ τών οποίων πανεπιστήμια, ογκολογικά ινστιτούτα, κέντρα ερευνών, Ευρωπαϊκές οργανώσεις ασθενών, φαρμακευτικές εταιρείες, επιστημονικές ιατρικές εταιρείες, προϊόν της εθελοντικής συνεργασίας της Ευρωπαϊκής ογκολογικής κοινότητας είναι ο οδηγός για την άριστη παροχή ογκολογικής περίθαλψης αλλά και για την κατάρτιση σύγχρονου Εθνικού Σχεδίου Δράσης
The Role of Patients & their Challenges in Clinical TrialsKathi Apostolidis
What are clinical trials
Myths about clinical trials
What patients want
The role of patients in clinical trials
How to communicate trial information
How to communicate trial results
The cross-border that became a European law in 2013 has many valuable provisions but its implementation seems almost impossible due the complex European health care reimbursement systems, lack of information for patients, delay in establishing Eur. Reference Centers,
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...Kathi Apostolidis
Τι περιμένει ο ογκολογικός ασθενής από την επικοινωνία με την ιατρική ομάδα που έχει αναλάβει τη περίθαλψή του;
Η σημασία της αφήγησης της ασθένειας για το γιατρό
mhealth in cancer supportive care - how eSMART can improve quality of lifeKathi Apostolidis
several mhealth apps already in cancer care but lots need still to be done-patients want safely accessible, transferable data everywhere-eSMART project using ASyMS promises to improve the quality of life of cancer patients undergoing chemotherapy- mhealth conference at Bocconi University - Milan
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...Kathi Apostolidis
A presentation on the content of the Greek patient rights legislation and how patients can make use of it-Παρουσίαση για την νομοθεσία για τα δικαιώματα των ασθενών και πως μπορούν να τα ασκήσουν
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
ESMO-ECPC Cancer Survivorship Guide
1. ESMO-ECPC Cancer Survivorship Guide
&
Cancer Survivorship Plan
A unique care and cancer advocacy tool
Kathi Apostolidis - ECPC Vice President
Hellenic Cancer Federation - ELLOK President
European Cancer Patient Coalition – Annual General Meeting – June 7-9, 2018 - Brussels
2.
3. ECPC: The patient voice in Brussels
Survivorship
Background ECPC Action
• Advocate against social
stigma
• Support implementation of
CanCon recommendations
on Survivorship
• Cancer is a public health
but ALSO a social-
economic issue
• Active involvement in JA
CanCon recommendations
for cancer survivorship
• ECPC-ESMO Guide for
Cancer Survivorship
4. CANCON: EU funded joint action of 17 EU associate member states and 65
collaborating partners for the development of guidelines for the harmonization of
the national cancer plans for cancer control
WP 8: Survivorship and Rehabilitation developed a high quality European
framework for survivorship and rehabilitation
Recommendations of WP8: they cover all aspects and all areas of cancer control
from diagnosis to psycho-social rehabilitation.
- Based on the patients needs and condition
- Recommendations of cancer policy supporting health systems sustainability
and adoption by all member States, with emphasis on rehabilitation and
employment
European Joint Action for Cancer Control
CanCon
5. ECPC – ESMO Memorandum of Understanding
Μay 2016
Strengthens existing collaboration among ECPC and ESMO
Practical collaboration on concrete topics:
•Update of ESMO Guidelines
•Update of ESMO Patient Guides
•Creation of Survivorship Guide and survivorship
care plan
5
6. Authors: Dr. Nikolaos Mitsimponas and Dr. Stefan
Rauh representing ESMO
Contributors: Prof. Francesco De Lorenzo and Kathi
Apostolidis representing ECPC
Reviewers: Dr. Jane Turner, Julia Rowland, PhD, Paul
Jacobsen, PhD, Maria Die Trill, PhD and Prof. Luzia
Travado, PhD, representing IPOS
Acknowledgements: Dr. Svetlana Jezdic, Prof. Jean-
Yves Douillard, Claire Bramley, Francesca Longo,
Klizia Marinoni (ESMO Head Office) and Francesco
Florindi-ECPC
Survivorship Guide
Created by ESMO & ECPC
in collaboration with International Psycho-Oncology Society
7. Survivorship Care is about
• follow-up and late years care
• management of late effects of cancer
care
• improvement of quality of life
• sound psychological & emotional health
Defining Survivorship
8. Content of the Survivorship Guide
▪ Support in coping with the new reality - Who can help me?
▪ Life after initial treatment - How can I get my normal life
back?
▪ Preventive health - What lifestyle changes can I make to
achieve optimal physical and emotional health?
▪ Follow-up care:
▪ Detection and management of treatment- or tumour-
related symptoms
▪ Prevention and detection of cancer recurrence
▪ Prevention and early detection of new primary cancers for
patients and their family members
▪ Comorbidities and management of comorbidities
▪ Keeping a personal health record / Survivorship care plan
- Practical
recommendations
- Survivorship Care
Plan
- Glossary
13. Survivorship Guide & Care Plan:
A powerful advocacy tool
▪ Offers evidence based, reliable survivorship information by
the leading European medical oncology scientific
organization and umbrella cancer patient organization
▪ Offers a summary of family cancer history, cancer diagnosis,
treatment, adverse events, follow-up care in one easy to
consult form
▪ Useful tool for all medical professionals that the
patient/survivor may consult after end of treatment
▪ Can be easily integrated to discharge instructions
14. Advocacy for the adoption
of the Survivorship Care Plan in Greece
▪ Build strong collaborations with medical cancer societies –
Seek their endorsement of the Guide
▪ Present how the Survivorship Care Plan will facilitate their
work
▪ Make it widely known
▪ Convince health care system officials about the benefits of
the plan
Advocacy Goal:
Make the Survivorship Care Plan
a mandatory integral part of the discharge instructions
15. Practical steps
▪ Translate the guide in your language
▪ Organize a press conference to present it
▪ Distribute widely to patients, hospitals, local press and key
opinion leaders
▪ Meet hospital administrators, oncology dept. directors, health
policy makers, Health Ministry to present the guide
▪ Use every opportunity to speak about it in conferences, tv
shows, interviews, community events in which you are invited
▪ Use the power of social media to promote and make the guide
known
16. Be persistent, Be patient, Use evidence
Be a Change Agent
▪ Don’t get discouraged
▪ Results do take time to materialize
▪ Refine your tools and methods
▪ Build strong alliances around your goal
Ask for assistance
Keep us informed of your efforts
17. Thank you for your attention
Mail: kathi.apostolidis@ecpc.org
kathi.apostolidis@ellok.org
Twitter: @cancereu
Facebook: ECPC-EuropeanCancerPatientCoalition